(Reuters) - Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
An Indian government committee is reviewing patented drugs of foreign firms.. Read more.
Reuters
Related,
- Big Pharma presses US to quash cheap drug production in India - RT
Big Pharma pushes for U.S. action against India over patent worries
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment